Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Guillain-Barré Syndrome

Apr 16, 2026/Clinical Summary

Patients receive medical and pharmacological treatment as the primary intervention, and physical rehabilitation to address musculoskeletal weakness and neurologic dysfunction.

Why Isn't Postpartum Physical Therapy Standard Practice? It Should Be

May 9, 2022/Perspective

This is when physical therapy can have a strong impact — during a time of healing, hormonal shifts, and altered body mechanics.

Beating Burnout

Feb 1, 2019/Feature

Its causes are many. So are the ways in which PTs and PTAs can address it and reinvigorate their careers.

Creating a Written Portrait

Oct 1, 2018/Column

"Documenting value-based care" simply means painting a clear picture of the good things you're doing as a PT.

Targeting an Enhanced Year

Mar 1, 2015/Column

Helping clients hit their personal bulls eye.

PTJ: New APTA Telerehab Guidelines Cover Education, Implementation, and More

Mar 27, 2024/Review

The first-ever telerehab CPG created specifically for PTs and PTAs includes seven recommendations.

Congressional Advocacy by the Numbers: Together, We Are Driving Payment Progress

Feb 10, 2026/News

APTA members helped drive a wave of federal advocacy wins in 2025, including the reversal of years of stagnant Medicare payment. The numbers tell the story: growing bipartisan backing, expanded legislative momentum, and a unified profession pushing payment reform forward. Focused on advancing fair payment,

Payer Advocacy by the Numbers: APTA Members and Staff Driving Progress

Feb 4, 2026/Article

Efforts from APTA members and staff led to 26 million-plus people having direct access to physical therapist services – and that's just one of the 21 regulatory policy changes APTA staff advocated for in 2025. In 2025, APTA members and staff successfully advocated for meaningful payment reforms with

10-Meter Walk Test (10MWT) for Cerebral Palsy (CP)

Jan 15, 2015/Test & Measure

Target population: Children with neuromuscular disease, including cerebral palsy (CP).